2 Results for "

orthotopic PDAC models

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "orthotopic PDAC models" in MCE Product Catalog:

Cat. No.: HY-148409
CAS No.: 352693-80-2
Purity:  99.58%
연구분야:  

Cancer

MMRi62, a ferroptosis inducer targeting MDM2-MDM4 (negative regulators of tumor suppressor p53). MMRi62 shows a P53-independent pro-apoptotic activity against pancreatic ductal adenocarcinoma (PDAC) cells and induce autophagy. MMRi62 inducesferroptosis, resulting in a increase of reactive oxygen and lysosomal degradation of ferritin heavy chain (FTH1). MMRi62 also leads to proteasomal degradation of mutant p53, also inhibits orthotopic xenograft PDAC mouse model in vivo with high frequency mutation characteristics of KRAS and TP53.12 .
loading...
    loading...
Cat. No.: HY-189358
CAS No.: 901730-21-0
Target:  

Neurokinin Receptor ERK

연구분야:  

Inflammation/Immunology Cancer

TACR1-IN-1 is a TACR1 inhibitor. TACR1-IN-1 attenuates Substance P-driven ERK phosphorylation and downstream malignant programs. TACR1-IN-1 reduces PGP9.5-positive tumor innervation in orthotopic PDAC models. TACR1-IN-1 increases antigen presentation and immune chemokine-related transcript expression under Substance P treatment conditions. TACR1-IN-1 reverses Substance P-associated reduction in Gemcitabine (HY-17026) sensitivity. TACR1-IN-1 can be used for research on pancreatic ductal adenocarcinoma .
loading...
    loading...